We and our investors see exciting opportunities to invest in technology- and innovation-rich companies in the industrial and healthcare sectors, commented Jeff Kovach, Managing Partner of Arsenal. About Arsenal Capital PartnersArsenal Capital Partners is a leading private equity firm that specializes in investments in industrial growth and healthcare companies. You can read more about your. Copyright 2023 Dow Jones & Company, Inc. All Rights Reserved. The New York firm said Monday it closed its sixth flagship investment vehicle, Arsenal Capital Partners VI LP, at $4.3 billion. Patricia Grad, Partner and Head of Investor Relations of Arsenal, added, We are grateful for this global group of institutions and individuals who have supported our firm and greatly appreciate the collaborative dialogue that we had with them as we crafted these investment opportunities, particularly our debut Growth Fund. Direct links to the EDGAR source material. Private Equity Fund; North America; Arsenal Capital Partners Vi; Transaction Details. About Arsenal Capital Partners Arsenal Capital Partners is a leading New York -based private equity firm that invests in middle market specialty industrial and healthcare companies.. The Growth Fund will execute a similar strategy in the same markets but pursue investments in next generation, emerging technology businesses poised to apply innovation to generate very high growth. Arsenal Capital Partners Announces Final Closes of Two New Funds Working in genuine partnership with management teams and business owners, we craft custom, differentiated, multi-faceted high-growth strategies that provide value-add solutions to marketspaces. Arsenal Capital Partners VI LP, at $4.3 billion. site you are consenting to these choices. Arsenal Capital Partners VI LP (together with its parallel funds, "Fund VI") closed with $4.3 billion in capital commitments, well exceeding its $3.0 billion target of limited partner commitments and well above the size of its $2.4 billion predecessor fund. | Terms & Conditions The funding will help commercialise DefineMBCs three component tests, which combinedly offer a comprehensive blood-based biopsy result for metastatic breast cancer patients. Arsenal Capital Partners - CB Insights We are delighted that you'd like to resume your subscription. Fund VI Closes with $4.3 Billion and Surpasses $3.0 Billion Target, Inaugural Growth Fund Closes at its Hard Cap with $1.1 Billion and Surpasses $750 Million Target. Arsenal Capital Partners Fund History19 Fund Histories . Arsenal Capital Partners | LinkedIn Arsenal Capital Partners VI LP (together with its parallel funds, "Fund VI") closed with $4.3 billion in capital commitments, well exceeding its $3.0 billion target of limited partner commitments .
arsenal capital partners fund vi